Prescrire’s Packaging Awards are intended to draw
patients’ and healthcare professionals’ attention to the
fact that high-quality packaging is an important factor
in safe and effective treatment.
They also provide us with an opportunity to congratulate manufacturers that design patient-friendly packaging, and to encourage other manufacturers
to improve their packaging. Poor quality packaging
is awarded a yellow or red card, depending on the degree
of risk it creates.
Throughout the year the editorial staff examines the packaging
of all new drugs. They focus on the outer packaging
(the box), the primary internal packaging (bottle, blister
pack, tube, etc.), the patient information leaflet, and on any
devices provided for administration, such as spoons, graduated
oral syringes, syringes and needles for injection. The
unit doses are also evaluated for convenience of use and
patient safety (tablet divisibility, patch adhesiveness).
This systematic analysis is based on standardised forms.
It focuses on drug identifiers (labelling, printing, colour coding),
other items contributing to safe use (child-proof caps,
dose identifiers), and items helping to provide information
to patients (labels, package leaflets). The risk-benefit balance
of the product is also taken into account, along with the
categories of patients and caregivers most likely to use the
drug (e.g. children) and the modes of administration (especially
for self-medication).
At the end of each year, the Packaging Awards are granted
following a review of the year’s analytical forms, in total
independence and with no input from drug or packaging
manufacturers (rules available from www.prescrire.org).
© Prescrire April 2008
Source: Prescrire Int 2008; 17 (94): 76.